CEO of the SFDA Discusses Investment Opportunities with American Medical Companies

The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, welcomed a delegation of approximately 40 representatives from American medical companies today at the Authority's headquarters in Riyadh. Discussions centered on exploring investment opportunities within Saudi Arabia's healthcare sector.

Dr. Aljadhey highlighted key investment opportunities within the health sector during the meeting, emphasizing the SFDA's dedication to enhancing the investment environment. He outlined the support available to specialized medical companies for growth and expansion and reviewed the existing regulatory frameworks and legislation designed to facilitate investment.

This meeting is part of the SFDA's ongoing efforts to foster international partnerships and boost investments in health, ultimately improving the quality of health services and supporting the Saudi health transformation process.